[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].
Identifieur interne : 000352 ( Main/Exploration ); précédent : 000351; suivant : 000353[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].
Auteurs : Jesús Castilla [Espagne] ; Marcela Guevara ; Manuel García Cenoz ; Fátima Irisarri ; Maite Arriazu ; Aurelio BarricarteSource :
- Revista espanola de salud publica [ 2173-9110 ]
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Sous-type H1N1 du virus de la grippe A.
- prévention et contrôle : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine.
- Humains, Vaccination, Vaccins antigrippaux.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- MESH :
- chemical : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human.
- Humans, Vaccination.
Abstract
BACKGROUND
A specific vaccination campaign against influenza A (H1N1) was conducted in 2009. We evaluated its impact in Navarre.
METHODS
In the cohort of non-institutionalised population with chronic diseases covered by the Navarre Health Service (n=131,333), assuming 100% effectiveness from day 8 after administration of the pandemic vaccine, we estimated its impact on the prevention of influenza A (H1N1) 2009 cases and hospitalisations between weeks 47/2009 and 3/2010.
RESULTS
In the nine weeks of the study, 973 cases of influenza syndrome were diagnosed (7 per 1000); but only 28% were due to influenza A (H1N1) 2009. In addition, there were 14 hospitalisations with virological confirmation (11 per 100,000). With 19% coverage with the pandemic vaccine (versus 40% with the seasonal vaccine), 7.7% of cases and 10.5% of hospitalisations were prevented during the study period. For each case prevented, 1092 doses of pandemic vaccine were administered, and for each hospitalisation avoided 15,021 doses were administered. If coverage had been the same as for the seasonal vaccine, it would have been possible to prevent 16.2% of cases and 22.2% of hospitalisations. If coverage had been double than for the seasonal vaccine and vaccination campaign had taken place two weeks earlier, it would have been possible to prevent 70.7% of cases and 68.0% of hospitalizations, with 261 doses needed to prevent one case and 6206 doses to avoid one hospitalisation.
CONCLUSION
Despite the high effectiveness of the vaccine, its impact in Navarre has been minimal due to low coverage and late initiation of the vaccination campaign.
DOI: 10.1590/S1135-57272011000100013
PubMed: 21750849
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].</title><author><name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name><affiliation wicri:level="1"><nlm:affiliation>Instituto de Salud Pública de Navarra, Leyre 15, Pamplona. jcastilc@navarra.es</nlm:affiliation><country wicri:rule="url">Espagne</country></affiliation></author><author><name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name></author><author><name sortKey="Garcia Cenoz, Manuel" sort="Garcia Cenoz, Manuel" uniqKey="Garcia Cenoz M" first="Manuel" last="García Cenoz">Manuel García Cenoz</name></author><author><name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name></author><author><name sortKey="Arriazu, Maite" sort="Arriazu, Maite" uniqKey="Arriazu M" first="Maite" last="Arriazu">Maite Arriazu</name></author><author><name sortKey="Barricarte, Aurelio" sort="Barricarte, Aurelio" uniqKey="Barricarte A" first="Aurelio" last="Barricarte">Aurelio Barricarte</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011 Jan-Feb</date><idno type="RBID">pubmed:21750849</idno><idno type="pmid">21750849</idno><idno type="doi">10.1590/S1135-57272011000100013</idno><idno type="wicri:Area/Main/Corpus">00356</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00356</idno><idno type="wicri:Area/Main/Curation">000356</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000356</idno><idno type="wicri:Area/Main/Exploration">000356</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].</title><author><name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name><affiliation wicri:level="1"><nlm:affiliation>Instituto de Salud Pública de Navarra, Leyre 15, Pamplona. jcastilc@navarra.es</nlm:affiliation><country wicri:rule="url">Espagne</country></affiliation></author><author><name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name></author><author><name sortKey="Garcia Cenoz, Manuel" sort="Garcia Cenoz, Manuel" uniqKey="Garcia Cenoz M" first="Manuel" last="García Cenoz">Manuel García Cenoz</name></author><author><name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name></author><author><name sortKey="Arriazu, Maite" sort="Arriazu, Maite" uniqKey="Arriazu M" first="Maite" last="Arriazu">Maite Arriazu</name></author><author><name sortKey="Barricarte, Aurelio" sort="Barricarte, Aurelio" uniqKey="Barricarte A" first="Aurelio" last="Barricarte">Aurelio Barricarte</name></author></analytic><series><title level="j">Revista espanola de salud publica</title><idno type="eISSN">2173-9110</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (MeSH)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Spain (epidemiology)</term><term>Vaccination (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Espagne (épidémiologie)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Vaccination (MeSH)</term><term>Vaccins antigrippaux (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Vaccination</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>A specific vaccination campaign against influenza A (H1N1) was conducted in 2009. We evaluated its impact in Navarre.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>In the cohort of non-institutionalised population with chronic diseases covered by the Navarre Health Service (n=131,333), assuming 100% effectiveness from day 8 after administration of the pandemic vaccine, we estimated its impact on the prevention of influenza A (H1N1) 2009 cases and hospitalisations between weeks 47/2009 and 3/2010.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>In the nine weeks of the study, 973 cases of influenza syndrome were diagnosed (7 per 1000); but only 28% were due to influenza A (H1N1) 2009. In addition, there were 14 hospitalisations with virological confirmation (11 per 100,000). With 19% coverage with the pandemic vaccine (versus 40% with the seasonal vaccine), 7.7% of cases and 10.5% of hospitalisations were prevented during the study period. For each case prevented, 1092 doses of pandemic vaccine were administered, and for each hospitalisation avoided 15,021 doses were administered. If coverage had been the same as for the seasonal vaccine, it would have been possible to prevent 16.2% of cases and 22.2% of hospitalisations. If coverage had been double than for the seasonal vaccine and vaccination campaign had taken place two weeks earlier, it would have been possible to prevent 70.7% of cases and 68.0% of hospitalizations, with 261 doses needed to prevent one case and 6206 doses to avoid one hospitalisation.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Despite the high effectiveness of the vaccine, its impact in Navarre has been minimal due to low coverage and late initiation of the vaccination campaign.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21750849</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2016</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2173-9110</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>1</Issue><PubDate><MedlineDate>2011 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>Revista espanola de salud publica</Title><ISOAbbreviation>Rev. Esp. Salud Publica</ISOAbbreviation></Journal><ArticleTitle>[Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].</ArticleTitle><Pagination><MedlinePgn>105-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1135-57272011000100013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1135-57272011000100013</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A specific vaccination campaign against influenza A (H1N1) was conducted in 2009. We evaluated its impact in Navarre.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the cohort of non-institutionalised population with chronic diseases covered by the Navarre Health Service (n=131,333), assuming 100% effectiveness from day 8 after administration of the pandemic vaccine, we estimated its impact on the prevention of influenza A (H1N1) 2009 cases and hospitalisations between weeks 47/2009 and 3/2010.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the nine weeks of the study, 973 cases of influenza syndrome were diagnosed (7 per 1000); but only 28% were due to influenza A (H1N1) 2009. In addition, there were 14 hospitalisations with virological confirmation (11 per 100,000). With 19% coverage with the pandemic vaccine (versus 40% with the seasonal vaccine), 7.7% of cases and 10.5% of hospitalisations were prevented during the study period. For each case prevented, 1092 doses of pandemic vaccine were administered, and for each hospitalisation avoided 15,021 doses were administered. If coverage had been the same as for the seasonal vaccine, it would have been possible to prevent 16.2% of cases and 22.2% of hospitalisations. If coverage had been double than for the seasonal vaccine and vaccination campaign had taken place two weeks earlier, it would have been possible to prevent 70.7% of cases and 68.0% of hospitalizations, with 261 doses needed to prevent one case and 6206 doses to avoid one hospitalisation.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Despite the high effectiveness of the vaccine, its impact in Navarre has been minimal due to low coverage and late initiation of the vaccination campaign.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castilla</LastName><ForeName>Jesús</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Salud Pública de Navarra, Leyre 15, Pamplona. jcastilc@navarra.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guevara</LastName><ForeName>Marcela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>García Cenoz</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Irisarri</LastName><ForeName>Fátima</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Arriazu</LastName><ForeName>Maite</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Barricarte</LastName><ForeName>Aurelio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><CollectiveName>Red de Médicos Centinela</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Red de Vigilancia Epidemiológica y Microbiológica de Gripe de Navarra</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Impacto de la vacunación frente a la gripe (H1N1) 2009 en Navarra: comparación de diferentes escenarios.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Salud Publica</MedlineTA><NlmUniqueID>9600212</NlmUniqueID><ISSNLinking>1135-5727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21750849</ArticleId><ArticleId IdType="pii">S1135-57272011000100013</ArticleId><ArticleId IdType="doi">10.1590/S1135-57272011000100013</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Arriazu, Maite" sort="Arriazu, Maite" uniqKey="Arriazu M" first="Maite" last="Arriazu">Maite Arriazu</name><name sortKey="Barricarte, Aurelio" sort="Barricarte, Aurelio" uniqKey="Barricarte A" first="Aurelio" last="Barricarte">Aurelio Barricarte</name><name sortKey="Garcia Cenoz, Manuel" sort="Garcia Cenoz, Manuel" uniqKey="Garcia Cenoz M" first="Manuel" last="García Cenoz">Manuel García Cenoz</name><name sortKey="Guevara, Marcela" sort="Guevara, Marcela" uniqKey="Guevara M" first="Marcela" last="Guevara">Marcela Guevara</name><name sortKey="Irisarri, Fatima" sort="Irisarri, Fatima" uniqKey="Irisarri F" first="Fátima" last="Irisarri">Fátima Irisarri</name></noCountry><country name="Espagne"><noRegion><name sortKey="Castilla, Jesus" sort="Castilla, Jesus" uniqKey="Castilla J" first="Jesús" last="Castilla">Jesús Castilla</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000352 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000352 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21750849
|texte= [Impact of vaccination against influenza (H1N1) 2009 in Navarre: comparison of different scenarios].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21750849" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |